Your browser doesn't support javascript.
loading
LINC01572 is a Novel Prognostic Biomarker and Therapeutic Target in Lung Adenocarcinoma.
Zheng, Yaolin; Zhang, Zhenshan; Li, Xueyan; Wu, Leilei; Liu, Xinliang; Liu, Liang; Chen, Jiayan; Wei, Dongping.
Afiliación
  • Zheng Y; Department of Oncology, Nanjing First Hospital, Nanjing Medical University, 210006 Nanjing, Jiangsu, China.
  • Zhang Z; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, 200000 Shanghai, China.
  • Li X; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, 200120 Shanghai, China.
  • Wu L; Department of Oncology, Nanjing First Hospital, Nanjing Medical University, 210006 Nanjing, Jiangsu, China.
  • Liu X; Department of Radiation Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, 200433 Shanghai, China.
  • Liu L; Department of Endocrinology, People's Hospital of Xuyi, 211700 Xuyi, Jiangsu, China.
  • Chen J; Department of Radiation Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, 200433 Shanghai, China.
  • Wei D; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, 200000 Shanghai, China.
Front Biosci (Landmark Ed) ; 28(10): 257, 2023 10 20.
Article en En | MEDLINE | ID: mdl-37919058

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Adenocarcinoma / Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Límite: Animals / Humans Idioma: En Revista: Front Biosci (Landmark Ed) Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Adenocarcinoma / Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Límite: Animals / Humans Idioma: En Revista: Front Biosci (Landmark Ed) Año: 2023 Tipo del documento: Article País de afiliación: China